000 01311 a2200373 4500
005 20250514051905.0
264 0 _c20030520
008 200305s 0 0 eng d
022 _a0378-5173
024 7 _a10.1016/s0378-5173(02)00533-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeda, M
245 0 0 _aEquivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy.
_h[electronic resource]
260 _bInternational journal of pharmaceutics
_cDec 2002
300 _a247-55 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAlbuterol
_xadministration & dosage
650 0 4 _aConfidence Intervals
650 0 4 _aCross-Over Studies
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNebulizers and Vaporizers
650 0 4 _aPowders
650 0 4 _aTherapeutic Equivalency
700 1 _aZanen, P
700 1 _ade Boer, A H
700 1 _aGjaltema, D
700 1 _aAjaoud, A
700 1 _aBarends, D M
700 1 _aFrijlink, H W
773 0 _tInternational journal of pharmaceutics
_gvol. 249
_gno. 1-2
_gp. 247-55
856 4 0 _uhttps://doi.org/10.1016/s0378-5173(02)00533-1
_zAvailable from publisher's website
999 _c12240438
_d12240438